Gene · 406936
Papers3,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Tumor Suppressive miR-144-5p Targets: FAM111B Expression Accelerates the Malignant Phenotypes of Lung Adenocarcinoma. | Int J Mol Sci | 2024 | 39337462 | PubTator, text mining | PubMed |
| MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study. | Noncoding RNA | 2024 | 39311383 | PubTator, text mining | PubMed |
| Circulating miRNAs as Biomarkers of Subclinical Atherosclerosis Associated with Severe Obesity before and after Bariatric Surgery. | Obes Facts | 2024 | 39236703 | PubTator, text mining | PubMed |
| Exploring the cytoprotective role of mesenchymal stem Cell-Derived exosomes in chronic liver Fibrosis: Insights into the Nrf2/Keap1/p62 signaling pathway. | Int Immunopharmacol | 2024 | 39178516 | PubTator, text mining | PubMed |
| [Investigation of hsa-miR-1908 and hsa-miR-144 Expression Levels in Crimean-Congo Hemorrhagic Fever Patients]. | Mikrobiyol Bul | 2024 | 39046213 | PubTator, text mining | PubMed |
| BK Polyomavirus microRNA in Kidney Transplant Recipient. | Transplant Proc | 2024 | 38991903 | PubTator, text mining | PubMed |
| [Expression of MiR-144/451 in Different Types of Anemia]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 38926974 | PubTator, text mining | PubMed |
| Circulating MicroRNA as a Potential Biomarker for Skeletal Disease in Primary Hyperparathyroidism: A Case-control Study. | Ann Surg | 2024 | 38881439 | PubTator, text mining | PubMed |
| Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis. | Front Psychiatry | 2024 | 38827444 | PubTator, text mining | PubMed |
| Contribution of FOS in neutrophils to venous thromboembolism via miR-144 based on bioinformatic prediction and validation. | J Cell Mol Med | 2024 | 38818568 | PubTator, text mining | PubMed |
| MicroRNA profiling in women with migraine: effects of CGRP-targeting treatment. | J Headache Pain | 2024 | 38755568 | PubTator, text mining | PubMed |
| Paediatrics congenital heart disease is associated with plasma miRNAs. | Pediatr Res | 2024 | 38755412 | PubTator, text mining | PubMed |
| The miR-144/Hmgn2 regulatory axis orchestrates chromatin organization during erythropoiesis. | Nat Commun | 2024 | 38714702 | PubTator, text mining | PubMed |
| Author Correction: Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway. | Acta Pharmacol Sin | 2024 | 38684802 | PubTator, text mining | PubMed |
| Use of steric blocking antisense oligonucleotides for the targeted inhibition of junction containing precursor microRNAs. | bioRxiv | 2024 | 38645194 | PubTator, text mining | PubMed |
| A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis. | BMC Infect Dis | 2024 | 38622570 | PubTator, text mining | PubMed |
| Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line. | Med Oncol | 2024 | 38592567 | PubTator, text mining | PubMed |
| Bubble DNA tweezer: A triple-conformation sensor responsive to concentration-ratios. | iScience | 2024 | 38361618 | PubTator, text mining | PubMed |
| Plasma-derived exosomal miRNA profiles associated with type 1 diabetes. | Diabetes Metab Res Rev | 2024 | 38340050 | PubTator, text mining | PubMed |
| [Plasma miRNA expression in patients with genetically confirmed multiple endocrine neoplasia type 1 syndrome and its phenocopies]. | Probl Endokrinol (Mosk) | 2024 | 38311997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406936/papers?page=4